Samsca Liver Injury Warning Issued By FDA
Federal drug experts are placing a one month limit on the recommended use of Samsca, a hyponatremia drug that has been linked to a risk of liver damage.
Federal drug experts are placing a one month limit on the recommended use of Samsca, a hyponatremia drug that has been linked to a risk of liver damage.
Federal health regulators are warning that the hyponatremia drug Samsca may cause severe and potentially fatal liver damage.